Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

5.7%

3 terminated out of 53 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

6%

3 trials in Phase 3/4

Results Transparency

42%

10 of 24 completed with results

Key Signals

10 with results89% success

Data Visualizations

Phase Distribution

37Total
Not Applicable (23)
Early P 1 (1)
P 1 (5)
P 2 (5)
P 3 (1)
P 4 (2)

Trial Status

Completed24
Unknown12
Recruiting6
Terminated3
Active Not Recruiting3
Enrolling By Invitation2

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT07559292Not ApplicableEnrolling By InvitationPrimary

Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes

NCT06627179Phase 2Recruiting

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

NCT06098677Not ApplicableNot Yet RecruitingPrimary

Effect of Carotenoids Supplementation on Visual Function in Chinese Subjects

NCT05600140Not ApplicableRecruitingPrimary

Viewing Strategy Training in Children With (Cerebral) Visual Impairment

NCT04428541Not ApplicableCompleted

Determination of the Validity of a Questionnaire to Assess the Visual Function of Preverbal Children With Operable Bilateral Ocular Pathologies

NCT07085533Recruiting

Natural History Study of Inherited Retinal Diseases

NCT02911805Not ApplicableActive Not RecruitingPrimary

Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation

NCT05921240Enrolling By InvitationPrimary

Unmet Needs, Barriers and Facilitators to Vision Services for Children and Adolescents With Special Vision

NCT07140783Phase 3Recruiting

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

NCT02679313Not ApplicableWithdrawnPrimary

Effect of Lens Presentation on the Clinical Oculomotor Assessment at Near

NCT06992622Recruiting

Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis

NCT04141891Not ApplicableCompleted

Advancing Understanding of Transportation Options

NCT06085430Not ApplicableCompleted

Kubota Glass Parameter Refinement Study

NCT03913130Phase 1Terminated

Extension Study to Study PQ-110-001 (NCT03140969)

NCT05176717Phase 2Terminated

Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)

NCT05158296Phase 2Terminated

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

NCT06451172Early Phase 1Recruiting

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

NCT06077682Phase 4Unknown

Cycloplegic Refraction in Pediatric Patients With Esotropia

NCT05209581Completed

Assessment of Visual Acuity in Refugee Population

NCT05835193Completed

Pre-symptomatic Screening of Visual Acuity in Pre-school Students

Scroll to load more

Research Network

Activity Timeline